A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Public ClinicalTrials.gov record NCT06559150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo- Controlled Study of Ensifentrine in Subjects With Non-Cystic Fibrosis Bronchiectasis
Study identification
- NCT ID
- NCT06559150
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Industry
- Enrollment
- 284 participants
Conditions and interventions
Conditions
Interventions
- Nebulized Ensifentrine Suspension; 3 mg Drug
- Nebulized Placebo Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2024
- Primary completion
- Sep 23, 2027
- Completion
- Sep 23, 2027
- Last update posted
- May 4, 2026
2024 – 2027
United States locations
- U.S. sites
- 29
- U.S. states
- 22
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kirklin Clinic of UAB Hospital | Birmingham | Alabama | 35233 | Recruiting |
| So Cal Institute for Respiratory Diseases, Inc. | Los Angeles | California | 90048 | Recruiting |
| University of California Davis Medical Center | Sacramento | California | 95817 | Recruiting |
| National Jewish Health Main Campus | Denver | Colorado | 80206 | Recruiting |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | Recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| Emory University at Saint Joseph Pulmonary Clinic | Atlanta | Georgia | 30342 | Recruiting |
| Augusta University | Augusta | Georgia | 30912 | Recruiting |
| ASHA Clinical Research | Hammond | Indiana | 46324 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| University of Kansas Medical Center-Kansas City | Kansas City | Kansas | 66160 | Recruiting |
| Massachusetts General Hospital- 55 Fruit St | Boston | Massachusetts | 02114 | Recruiting |
| University of Michigan Hospital | Ann Arbor | Michigan | 48109 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Recruiting |
| NYU Langone Health Pulmonary and Critical Care Associates, P.C. - BRANY - PPDS | New York | New York | 10016 | Recruiting |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | Recruiting |
| Accellacare of Wilmington | Wilmington | North Carolina | 28401 | Terminated |
| Southeastern Research Center | Winston-Salem | North Carolina | 27103 | Recruiting |
| Ohio State University | Columbus | Ohio | 43221 | Recruiting |
| Oregon Health and Science University | Portland | Oregon | 97239 | Recruiting |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | Recruiting |
| Medical University of South Carolina (MUSC) - PPDS | Charleston | South Carolina | 29425 | Recruiting |
| Velocity Clinical Research - Spartanburg - PPDS | Spartanburg | South Carolina | 29303 | Recruiting |
| Velocity Clinical Research - Union - PPDS | Union | South Carolina | 29379 | Recruiting |
| Clinical Trials Center of Middle Tennessee | Franklin | Tennessee | 37067 | Recruiting |
| The Respire Institute | Houston | Texas | 77094 | Recruiting |
| UT Texas Health Science at Tyler | Tyler | Texas | 75708 | Recruiting |
| TPMG Clinical Research | Williamsburg | Virginia | 23188 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06559150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06559150 live on ClinicalTrials.gov.